Morii Takeshi, Iwata Shintaro, Yamaga Kensaku, Okamoto Masanori, Ando Kosei, Tanaka Takaaki, Nishida Jun
Department of Orthopaedic Surgery, School of Medicine, Kyorin University, 6-20-2 Shinkawa, Mitaka-shi 181-8611, Tokyo, Japan.
Department of Musculoskeletal Oncology and Rehabilitation Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku 104-0045, Tokyo, Japan.
Curr Oncol. 2025 Aug 12;32(8):453. doi: 10.3390/curroncol32080453.
While changes in clinical practice during the COVID-19 pandemic in Japan have been widely studied, data specific to bone and soft tissue tumor care remain limited.
A nationwide web-based survey was conducted among hospitals specializing in musculoskeletal tumors. It assessed the occurrence of COVID-19-related events (patient infections, outbreak clusters, and staff infections), delays in referral and diagnosis, postponement or cancellation of specific treatments, and changes in institutional management strategies.
Seventy-eight hospitals (91.7% of all specialized centers) responded. Patient infections, outbreak clusters, and staff infections were reported by 28.2%, 48.7%, and 53.8% of hospitals, respectively. While radiological exams and biopsies were largely maintained, patient referrals decreased significantly. Surgical treatment was more affected than chemotherapy or radiotherapy. Strategy changes included surgery delays or cancellations (48.7%) and prolonged follow-up intervals (20.5%). Among COVID-19-related factors, only direct patient infections were significantly associated with institutional changes in treatment policy.
The pandemic substantially disrupted outpatient services and surgical care in musculoskeletal oncology. Patient infection was the main driver of treatment strategy modifications.
虽然日本在新冠疫情期间临床实践的变化已得到广泛研究，但骨骼和软组织肿瘤护理的具体数据仍然有限。
对全国范围内的肌肉骨骼肿瘤专科医院进行了一项基于网络的调查。该调查评估了与新冠相关事件（患者感染、暴发聚集和工作人员感染）的发生情况、转诊和诊断的延迟、特定治疗的推迟或取消以及机构管理策略的变化。
78家医院（占所有专科医院的91.7%）做出了回应。分别有28.2%、48.7%和53.8%的医院报告了患者感染、暴发聚集和工作人员感染情况。虽然放射检查和活检基本得以维持，但患者转诊显著减少。手术治疗比化疗或放疗受到的影响更大。策略变化包括手术延迟或取消（48.7%）以及随访间隔延长（20.5%）。在与新冠相关的因素中，只有直接的患者感染与治疗政策的机构变化显著相关。
疫情严重扰乱了肌肉骨骼肿瘤学的门诊服务和手术护理。患者感染是治疗策略调整的主要驱动因素。
